Edwards, The 'Cleanest Large-Cap Medtech Story,' Launches On Second-Quarter Beat

Shares of Edwards Lifesciences surged on Friday following the company's better-than-expected financial results, surpassing both revenue and profit projections set by Wall Street analysts. The medtech company is being hailed as the "cleanest large-cap medtech story" after its strong performance in the second quarter. The stock launch saw impressive gains, highlighting the positive reception from investors to the company's financial success.